Explore Stanford technologies available for licensing:

The Tass Lab has invented non-invasive, Vibrotactile Coordinated Reset (vCR) stimulation devices and methods to safely and efficiently treat brain disorders characterized by abnormal neuronal synchrony such as Parkinson's disease.

The Tass Lab has invented non-invasive, Vibrotactile Coordinated Reset (vCR) stimulation devices and methods to safely and efficiently treat brain disorders characterized by abnormal neuronal synchrony such as Parkinson's disease.

The Tass Lab has invented non-invasive, Vibrotactile Coordinated Reset (vCR) stimulation devices and methods to safely and efficiently treat brain disorders characterized by abnormal neuronal synchrony such as Parkinson's disease.

The blood-brain barrier (BBB) lumen is coated by a carbohydrate-rich meshwork known as the brain endothelial glycocalyx layer. Stanford researchers have shown that the brain endothelial glycocalyx is highly dysregulated during aging and neurodegenerative disease.

Creating human brain progenitors and neurons from human pluripotent stem cells (hPSCs) offers vast possibilities to study, model and treat neurological and neurodegenerative diseases, which are among the most intractable diseases that afflict our society.

Stanford scientists have discovered that using silent mutations to alter codon:anticodon affinity can be used to tune clonal expansion in CD8 T cells.

Stanford researchers have developed a method to suppress immune responses to RNA therapy by chemically treating the RNA with an acylating reagent.

Researchers at Stanford University have discovered a novel way of treating dry age-related macular degeneration by inhibiting a causal disease target.

Stanford researchers have developed a nanoparticle adjuvant with spatiotemporal controlled release of TLR7 agonist for broad protection against influenza or SARS-CoV-2.

Researchers at Stanford have developed practical applications that use germline information (e.g., germline epitope burden) for diagnosis, monitoring and treatment of cancer.

Researchers at Stanford have created human induced pluripotent stem cells (hiPSCs) derived from adult human dermal fibroblasts exposed to an environmental factor.

Obtaining pure cell types from mixed cell populations continues to be a significant obstacle in the fields of stem cell biology and regenerative medicine.

Stanford researchers have developed a novel technique, enabling specific labeling and purification of regenerating and non-regenerating retinal ganglion cells from the same animals with the same genetic background/modification/injuries.

Researchers at Stanford have developed a new avenue for stimulating T effector and Treg immune cells in an antigen-specific manner.

Cell culture is a central technique used for a plethora of research applications including in the modeling of complex diseases, creating transgenic animals, gene therapy, cell therapy, regenerating lost tissue, and organ biogenesis.